The Effect of Platelet-Rich Plasma on Allograft Transplantation after Curettage in Benign Bone Tumor
![]() |
Kim, Jae-Do
(Department of Orthopaedic Surgery, Kosin University Gospel Hospital)
Kim, Ji-Youn (Department of Orthopaedic Surgery, Kosin University Gospel Hospital) Jang, Su-Jin (Department of Orthopaedic Surgery, Kosin University Gospel Hospital) Chung, So-Hak (Department of Orthopaedic Surgery, Kosin University Gospel Hospital) Jung, Gu-Hee (Department of Orthopaedic Surgery, Kosin University Gospel Hospital) |
1 | Veillette CJ, McKe MD. Growth factors - BMPs, DBMs, and buff y coat products: are there any proven diff erences amongst them? Injury. 2007;38 Suppl 1:38-48. |
2 | Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16:1043-54. DOI ScienceOn |
3 | Marx RE. Platelet-rich plasma: evidence to support its use. Maxillofac Surg. 2004;62:489-96. |
4 | Wilde AH, Schickendantz MS, Stulberg BN, Go RT. Th e incorporation of tibial allograft s in total knee arthroplasty. J Bone Joint Surg. 1990;72:815-24. DOI |
5 | Stevenson S, Horowitz M. The response to bone allografts. J Bone Joint Surg. 1992;74:939-50. DOI |
6 | Bouxsein ML, Turek TJ, Blake Ca, et al. Recombinant hu man bone morphogenetic protein-2 accelerates healing in a rab bit ulnar osteotomy model. J Bone Joint Surg. 2001;83:219-30. DOI |
7 | Yeh LC, Unda R, Lee JC. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol. 2000;185:87-97. DOI ScienceOn |
8 | Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Raiol Endod. 1998;85:638-46. DOI ScienceOn |
9 | Wrotniak M, Bielecki T, Gazdzik TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Orthop Traumatol Rehabil. 2007;9:227-38. |
10 | Dallari D, Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use of bone graft s supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg. 2007;89:2413-20. DOI ScienceOn |
11 | Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow- derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - a preliminary result of three cases. Bone. 2004;35:892-8. DOI ScienceOn |
12 | Delloye C, Cnockaert N, Cornu O. Bone substituetes in 2003: an overview. Acta Orthop Belg. 2003;69:1-8. |
13 | Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36 Suppl:20-7. |
14 | Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg. 2001;83:98-103. DOI |
15 | Bauer TW, Smith ST. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin Orthop Relat Res. 2002;395:11-22. DOI |
16 | Betz RR. Limitations of autograft and allograft : new synthetic solutions. Orthopedics. 2002;25 Suppl 5: 561-70. |
17 | Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegrad able orthopaedic implants for internal fixation: a review. Bio materials. 2000;21:2615-21. |
18 | Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000;371:10-27. DOI |
![]() |